Klitting, Raphaëlle http://orcid.org/0000-0002-7777-0308
Kafetzopoulou, Liana E. http://orcid.org/0000-0003-4531-1374
Thiery, Wim http://orcid.org/0000-0002-5183-6145
Dudas, Gytis http://orcid.org/0000-0002-0227-4158
Gryseels, Sophie
Kotamarthi, Anjali
Vrancken, Bram http://orcid.org/0000-0001-6547-5283
Gangavarapu, Karthik
Momoh, Mambu
Sandi, John Demby
Goba, Augustine
Alhasan, Foday
Grant, Donald S. http://orcid.org/0000-0002-4329-0795
Okogbenin, Sylvanus
Ogbaini-Emovo, Ephraim
Garry, Robert F. http://orcid.org/0000-0002-5683-3250
Smither, Allison R.
Zeller, Mark
Pauthner, Matthias G. http://orcid.org/0000-0001-9212-4307
McGraw, Michelle
Hughes, Laura D. http://orcid.org/0000-0003-1718-6676
Duraffour, Sophie
Günther, Stephan http://orcid.org/0000-0002-6562-0230
Suchard, Marc A. http://orcid.org/0000-0001-9818-479X
Lemey, Philippe http://orcid.org/0000-0003-2826-5353
Andersen, Kristian G.
Dellicour, Simon http://orcid.org/0000-0001-9558-1052
Article History
Received: 30 September 2021
Accepted: 2 September 2022
First Online: 27 September 2022
Competing interests
: R.F.G. is a co-founder of Zalgen Labs, a biotechnology company developing countermeasures for emerging viruses. The other authors declare no competing interest.